Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
ACASTI PHARM-TS (V.APO) had Return on Tangible Equity of 1168.06% for the most recently reported fiscal year, ending 2018-03-31.
| Income Statement Financials | |
-- |
|
-16.75M |
|
-- |
|
-- |
|
-- |
|
-15.35M |
|
-- |
|
-16.75M |
|
-16.75M |
|
-16.75M |
|
-16.75M |
|
-16.75M |
|
-16.75M |
|
-15.35M |
|
-13.26M |
|
0.36M |
|
0.36M |
|
-45.99 |
|
-45.99 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
17.89M |
|
-- |
|
-- |
|
-- |
|
11.48M |
|
6.41M |
|
-1.43M |
|
6.41M |
|
0.53M |
|
| Cash Flow Statement Financials | |
-9.75M |
|
-0.32M |
|
8.89M |
|
7.61M |
|
6.41M |
|
-1.21M |
|
0.72M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.42 |
|
-- |
|
-- |
|
0.16 |
|
0.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-261.48% |
|
|
Return on Tangible Equity |
1168.06% |
-93.66% |
|
-218.63% |
|
15.39 |
|
-27.74 |
|
-26.77 |
|